SLU-PP-332 Tracker
Track the "exercise mimetic" research compound
SLU-PP-332 is an experimental small molecule that activates the estrogen-related receptors (ERRα/β/γ). In animal studies it increased mitochondrial activity, endurance, and fat oxidation — earning the "exercise mimetic" nickname. Importantly, its evidence is preclinical (animal) only, with no human trials, and it is a research chemical, not an approved drug. Shotlee is the free app to log any protocol.
What is SLU-PP-332?
SLU-PP-332 is a synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ) — nuclear receptors that regulate energy metabolism and mitochondrial function. In mouse studies it boosted aerobic capacity, endurance, and fat burning without exercise, which is why it is described as an "exercise mimetic."
Crucially, all of this is preclinical: the published evidence is from animal models, and there are no human clinical trials, no approved use, and no established human dose. It is a research chemical only.
SLU-PP-332 Key Facts
What to Track in Shotlee
If you are documenting a protocol, log it cleanly.
Protocol FAQs
SLU-PP-332 is an experimental small-molecule agonist of the estrogen-related receptors (ERRα/β/γ). In mouse studies it increased endurance and fat oxidation, earning the "exercise mimetic" label. Its evidence is preclinical only — no human trials.
There is no human data. All published results are from animal models. Human safety, effectiveness, and dosing are unknown, and it is not an approved drug.
There is no established human dose because it has not been studied in humans. Animal-study doses do not translate to people. Treat any human use as unstudied and high-uncertainty.
No. It is a small-molecule nuclear-receptor agonist, not a peptide. It is sold as a research chemical, not an approved medicine.
Yes. Shotlee logs doses, weight, performance, vitals, and side effects — free.
Track Any Protocol in Shotlee
Free dose logging, weight and performance trends, and side effect tracking.